Unknown

Dataset Information

0

Lefamulin. Comment on: "Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270".


ABSTRACT: On 18 August 2019, an article was published in Microorganisms presenting novel, approved anti-Gram-positive antibiotics. On 19 August 2019, the U.S. Food and Drug Administration announced the approval of lefamulin, a representative of a new class of antibiotics, the pleuromutilins, for the treatment of adult community-acquired bacterial pneumonia. We present a brief description of lefamulin.

SUBMITTER: Koulenti D 

PROVIDER: S-EPMC6843636 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5923106 | BioStudies
2019-01-01 | S-EPMC6449572 | BioStudies
2019-01-01 | S-EPMC6853694 | BioStudies
2019-01-01 | S-EPMC6865224 | BioStudies
2018-01-01 | S-EPMC6253245 | BioStudies
2019-01-01 | S-EPMC6449575 | BioStudies
2016-01-01 | S-EPMC4914675 | BioStudies
2020-01-01 | S-EPMC7240345 | BioStudies
2020-01-01 | S-EPMC7314585 | BioStudies
2019-01-01 | S-EPMC6449570 | BioStudies